Treace Medical Concepts (TMCI) Non Operating Investment Income (2022 - 2026)
Treace Medical Concepts (TMCI) posted Non Operating Investment Income of -$98000.0 for Q1 2026, down 790.91% on a QoQ basis from -$11000.0 in Q4 2025, and down 145.0% year-over-year from $217777.8 in Q1 2025.
Treace Medical Concepts (TMCI) Non Operating Investment Income (2022 - 2026) Analysis & Trends
Treace Medical Concepts' Non Operating Investment Income history runs 5 years deep, the most recent figure standing at -$98000.0 for Q1 2026.
- Quarterly Non Operating Investment Income fell 145.0% year-over-year to -$98000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$83000.0 (down 591.67% YoY) and the FY2025 annual result came in at -$25000.0, up 62.12% from the prior year.
- Non Operating Investment Income was -$98000.0 for Q1 2026 at Treace Medical Concepts, down from -$11000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $311000.0 in Q4 2023 and bottomed at -$163000.0 in Q2 2023.
- A 5-year average of -$1857.1 and a median of -$28000.0 in 2022 frame the typical range for Non Operating Investment Income.
- Annual changes were most pronounced in 2023 — Non Operating Investment Income soared 1251.85% — and 2024, when it tumbled 224.14%.
- Treace Medical Concepts' Non Operating Investment Income stood at -$27000.0 in 2022, then surged by 1251.85% to $311000.0 in 2023, then slumped by 130.23% to -$94000.0 in 2024, then jumped by 88.3% to -$11000.0 in 2025, then slumped by 790.91% to -$98000.0 in 2026.
- Business Quant data shows TMCI's Non Operating Investment Income at -$98000.0 in Q1 2026, -$11000.0 in Q4 2025, and $33000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Treace Medical Concepts | 262.89 Mn | 211.04 Mn | 37.41 Mn | -98,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98,000.00 |
| Mar 31, 2026 | -98,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Sep 30, 2025 | 33,000.00 |
| Sep 30, 2025 | 33,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | -95,000.00 |
| Jun 30, 2024 | -95,000.00 |
| Mar 31, 2024 | -94,000.00 |
| Mar 31, 2024 | -94,000.00 |
| Dec 31, 2023 | 311,000.00 |
| Dec 31, 2023 | 311,000.00 |